Adempas

Medicinal product

(Invented) name

Adempas

Active substance (s)

Riociguatas

Strength

2,5 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C02KX05, Riociguat

Marketing authorisation holder

Abacus Medicine A/S, Danija

Date of authorisation

Date of renewal

Documents

Adempas_2.5 mg_Film-coated tablet_42 tablets_MA_013_06.07.2022.docx

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

CR-Lygiagretus platinimas

Qualitative and quantitative composition

Film-coated tablet	1 vnt.
Riociguatas	2,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
108974	95080	1095080	lizdinė plokštelė	N42		Receptinis	EU/1/13/907/013	Tiekiama	-	-	No	-	-

Stadijos

Data	Stadija
	Registruotas